![Ana I. Velázquez Mañana: Celebrate your Women in Oncology colleagues and friends at LEAD2024](https://oncodaily.com/pub/uploads/2024/08/GVdOIkyaQAAzeLG-e1724247044105.jpg)
Ana I. Velázquez Mañana: Celebrate your Women in Oncology colleagues and friends at LEAD2024
Ana I. Velázquez Mañana posted on X:
“Lift up and celebrate your Women in Oncology colleagues and friends!
Submit your nominations for the LEAD2024 Woman Oncologist of the Year Award and Rising Star Award by August 30th.”
Rebecca Shatsky shared Ana I. Velázquez Mañana’s post and added:
“Honored to be asked to speak at this wonderful conference this year!!! Women in Hematology-Oncology join me there at the Lowe’s in Coronado! You could not ask for a better location!”
Source: Ana I. Velázquez Mañana/X and Rebecca Shatsky/X
Ana Velázquez Mañana is an Assistant Professor of Medicine in the UCSF Division of Hematology/Oncology at Zuckerberg San Francisco General and a thoracic oncologist at the UCSF Helen Diller Family Comprehensive Cancer Center.
She serves as Assistant Director of Diversity, Equity, Inclusion, and Accessibility for Trainees of the UCSF Helen Diller Family Comprehensive Cancer Center and co-chairs the UCSF Department of Medicine Fellowship Diversity Committee. Her research, advocacy, and education efforts are focused on promoting and advancing health equity and workforce diversity.
Rebecca Shatsky is an Associate Professor at UC San Diego Health, Breast Medical Oncology Co-Team Leader, Scientific Director of the Inflammatory and Triple Negative Breast Cancer Program. She is a member of the NCCN guideline panel for Genetic/High-Risk Assessment of Breast, Ovarian and Pancreatic Cancer and the panel for the treatment of Cancer-Associated Pain.
Her work has been published in JAMA Oncology, Cancer Cell and Molecular Cancer Therapeutics, among others. Dr. Shatsky is a member of the American Association for Cancer Research and the American Society of Clinical Oncology.